MFDS — authorised 13 March 1996
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
MFDS authorised Crixivan on 13 March 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 13 March 1996.
MERCK SHARP DOHME holds the South Korean marketing authorisation.